选择地区语言
Using NGS technology, it detects fetal cell-free DNA in maternal peripheral blood plasma to analyze common high-incidence fetal chromosomal syndromes: Trisomy 21, Trisomy 18, and Trisomy 13. Routine prenatal screening has a high false-positive rate and increases the miscarriage risk associated with amniocentesis. NIPT reduces the rate of high-risk invasive prenatal screenings (such as amniocentesis) by 40% to 76%.
Platform Advantages
21.5-inch Extra-Large Touchscreen HMI, Full-Process Animated Guidance, and Ultra-Intuitive Control
Multiple throughput options and a range of instrument models—tailored to meet all your needs.
SE75 sequencing takes only 4.5 h, the competitive sequencing speed will keep your project running more smoothly.
Compatible with mainstream libraries on the market, eliminating debugging costs.
Sikun Integrated NGS Solution
Integrates Extraction, Library Construction, and Quality Control in One System.
Eliminates Tedious Operational Procedures, Ultra-Simple Operation.
Reduces analysis time to accelerate
critical clinical and research decisions.
